Pedal proof of concept study report
Predictive Oncology
JUNE 3, 2025
This Executive Overview outlines the proof-of-concept study completed by Predictive Oncology to illustrate the power of our active machine learning (AI) platform paired with our biobank of over 150,000 primary patient dissociated tumor samples. The described validation results demonstrate the generation of a predictive model that was able to accurately predict drug response across 130 samples and 175 drugs.
Let's personalize your content